We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of an oral contraceptive pill on follicular development in IVF/ICSI patients receiving a GnRH antagonist: a randomized study.
- Authors
Huirne, Judith A. F.; Van Loenen, Andre C. D.; Donnez, Jacques; Pirard, Céline; Homburg, Roy; Schats, Roel; McDonnell, Joseph; Lambalk, Cornelis B.
- Abstract
This randomized controlled study compared the effectiveness of a gonadotrophin releasing hormone (GnRH) antagonist protocol with or without oral contraceptive (OC) pretreatment on the number of oocytes retrieved in IVF or intracytoplasmic sperm injection (ICSI) patients. Sixty-four patients were randomized to start recombinant human FSH (r-hFSH) on day 2 or 3 after OC withdrawal (OC group) or on day 2 of a natural cycle (control group). From stimulation day 6 onwards, all patients were treated with daily (0.5 mg/ml) GnRH antagonist (Antide). OC pretreatment resulted in significantly lower starting concentrations of FSH, LH and oestradiol (P ≤ 0.001) and a thinner endometrium (P ≤ 0.0001). In the early stimulation period, fewer large follicles were found after OC pretreatment, leading to a significantly extended stimulation period (11.6 versus 8.7 days, P ≤ 0,0001) with more follicles on the day of recombinant human chorionic gonadotrophin administration (15.4 versus 12.5, P = 0.02) and more oocytes retrieved (13.5 versus 10.2, P ≤ 0.001) as compared with the control group. GnRH antagonist regimen, pretreated with OC, prevented the early endogenous FSH rise and improved follicular homogeneity, resulting in more oocytes. As a consequence of the extended treatment period, more rhFSH was required.
- Subjects
GONADOTROPIN releasing hormone; GONADOTROPIN; ORAL contraceptives; CHORIONIC gonadotropins; FOLLICLE-stimulating hormone
- Publication
Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2006, Vol 13, Issue 2, p235
- ISSN
1472-6483
- Publication type
Article
- DOI
10.1016/S1472-6483(10)60621-9